Clinical Trials List
Protocol NumberBAY 59-7939/16416
2014-02-28 - 2017-03-31
Phase III
Terminated3
-
Trial Applicant
COVANCE TAIWAN SERVICES LIMITED
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- Tze-Fan Chao Division of Cardiovascular Diseases
- Shih-Hsien Sung Division of Cardiovascular Diseases
- Tse-Min Lu Division of Cardiovascular Diseases
- Wen-Chung Yu Division of Cardiovascular Diseases
- 吳承學 Division of General Internal Medicine
- Kang-Ling Wang 醫學研究部
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Po-Yen Ko Division of Cardiovascular Diseases
- 陳恬恩 Division of Cardiovascular Diseases
- Chung-Ho Hsu Division of Cardiovascular Diseases
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
60 participants
-
Global
2880 participants
